RxDoctor Payments Data

John Kromalic, DO

Family Medicine · Fairlawn, OHNPI 1528134921

Payments from drug & device makers

$1,458in general payments, 2019–2025

Across 89 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$265
  • AstraZeneca$141
  • Pfizer$129
  • Astellas Pharma US Inc$117
  • Novo Nordisk$106
  • Exact Sciences$90
  • plus $608 from 18 others

What the payments were for

  • Food & beverage$1,458100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,458 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$65,539
Medicare patients
289
Services billed
1,622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban125$138,405
OzempicSemaglutide81$90,614
FarxigaDapagliflozin Propanediol51$58,321
MounjaroTirzepatide38$46,800
JanuviaSitagliptin Phosphate43$46,144
XareltoRivaroxaban32$29,839
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$24,652
JardianceEmpagliflozin14$21,231
TrulicityDulaglutide14$14,021
Breo ElliptaFluticasone/Vilanterol18$11,129
Fluticasone-SalmeterolFluticasone Propion/Salmeterol66$8,443
Atorvastatin Calcium654$5,748
Trijardy XrEmpaglifloz/Linaglip/Metformin11$5,413
SymbicortBudesonide/Formoterol Fumarate15$4,912
SynthroidLevothyroxine Sodium132$4,717

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$129$138,405125 claims
Novo NordiskOzempic$106$90,61481 claims
AstraZenecaFarxiga, Symbicort$141$63,23366 claims
Lilly USA, LLCMounjaro, Trulicity$79$60,82152 claims
MerckJanuvia$30$46,14443 claims
GSKTrelegy Ellipta, Breo Ellipta$76$35,78145 claims
Johnson & JohnsonXarelto$14$29,83932 claims
Boehringer IngelheimJardiance, Trijardy Xr$21$26,64325 claims
AbbVieSynthroid$265$4,717132 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Fairlawn

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →